Janux Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell JANX and other ETFs, options, and stocks.

About JANX

Janux Therapeutics, Inc. operates a preclinical stage biopharmaceutical company which engages in developing therapeutics based on the Tumor Activated T Cell Engager platform technology. The company was founded by David Campbell in June 2017 and is headquartered in San Diego, CA. 

CEO
David Campbell
CEODavid Campbell
Employees
81
Employees81
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2017
Founded2017
Employees
81
Employees81

JANX Key Statistics

Market cap
1.90B
Market cap1.90B
Price-Earnings ratio
-25.19
Price-Earnings ratio-25.19
Dividend yield
—
Dividend yield—
Average volume
563.14K
Average volume563.14K
High today
$32.38
High today$32.38
Low today
$31.20
Low today$31.20
Open price
$31.21
Open price$31.21
Volume
396.33K
Volume396.33K
52 Week high
$71.71
52 Week high$71.71
52 Week low
$22.52
52 Week low$22.52

Analyst ratings

92%

of 13 ratings
Buy
92.3%
Hold
7.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.